VPS35 Inhibitors are a class of compounds that target the vacuolar protein sorting 35 (VPS35) component of the retromer complex, a crucial player in endosomal trafficking and protein recycling within cells. VPS35 is part of a trimeric core complex, along with VPS26 and VPS29, which is responsible for recognizing and sorting transmembrane proteins for retrieval from endosomes back to the trans-Golgi network or to the plasma membrane. This process is vital for maintaining cellular homeostasis, as it ensures the proper localization and function of various receptors and transporters. Inhibition of VPS35 disrupts this recycling pathway, leading to altered cellular trafficking dynamics, which can be instrumental in studying the intricate balance of intracellular transport processes.
Research involving VPS35 Inhibitors allows scientists to delve into the mechanisms of protein sorting and recycling at a molecular level. By selectively inhibiting VPS35, researchers can observe the downstream effects on the trafficking and degradation of specific proteins, providing insights into how cells manage their protein cargo under different conditions. This is particularly important in understanding the role of endosomal sorting in cellular signaling, receptor downregulation, and the maintenance of cellular structures such as cilia. Additionally, VPS35 is implicated in the regulation of mitochondrial function and quality control, as it has been shown to interact with components involved in mitophagy, the process by which damaged mitochondria are selectively degraded. Inhibitors of VPS35 can thus serve as valuable tools for studying these diverse biological processes, allowing for a better understanding of how cells orchestrate complex trafficking and recycling pathways to maintain their functional integrity. This knowledge is crucial for mapping out the intricate networks that govern cellular logistics and the adaptive responses to environmental and intracellular changes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
While primarily known as an autophagy inhibitor, 3-MA can also affect VPS34, indirectly impacting VPS26 function within the retromer complex. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Similar to 3-MA, LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3Ks), including VPS34, and may indirectly affect VPS26 function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 202190 is a compound that inhibits p38 mitogen-activated protein kinase (MAPK), and it may have an impact on VPS26 function through downstream signaling pathways. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
While primarily known as an inhibitor of the Arf-GEF (Guanine nucleotide exchange factor) system, Brefeldin A can also disrupt vesicle trafficking and indirectly affect VPS26 function. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
A macrolide antibiotic that inhibits V-ATPase, thereby affecting the acidification of intracellular compartments and interfering with VPS function. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
A compound that disrupts intracellular cholesterol transport and affects lysosomal function, thereby impacting VPS protein activity. | ||||||
YM201636 | 371942-69-7 | sc-204193 | 5 mg | $217.00 | 6 | |
A PIKfyve inhibitor that affects endosome-to-Golgi retrograde transport, thus impacting VPS proteins involved in this process. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Another V-ATPase inhibitor that interferes with vesicular acidification and therefore VPS function. | ||||||